Twitter Linkedin Instagram
Twitter Linkedin Instagram

The following supporters have supported this educational program:

PLATINUM SUPPORT

GOLD SUPPORT

FACULTY REVIEW

FACULTY GROUP REVIEW AT THE END OF THE 12 MONTHS TO REFLECT ON KEY DEVELOPMENTS

If you would like additional information or have any questions, please email:

office@md-education.com

Get in touch with us

ORGANISED BY:

UK Office

MD Education Ltd
4/4a Bloomsbury Square, London , WC1A 2RP

USA Office

MD Education USA LLC,
4600 140th Avenue North, Suite 180,  Clearwater, Florida 33762

Privacy Policy  |  Cookie Policy

Developed by Unet

27. David Sallman
David Sallman

Moffitt Cancer Center, Tampa, Florida, USA

David Sallman, MD, is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, FL. His clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and myeloproliferative neoplasms. His research interests focus on the development of novel targeted therapeutic strategies for patients with MDS and AML, based on the underlying mutational drivers of each disease. He has authored numerous articles, books, book chapters, and abstracts and serves as reviewer for multiple journals. In 2017, he received the Young Investigator Grant from the MDS Foundation. 

19. Bart Scott
Bart Scott

University of Washington Medical Center, Seattle, Washington, USA

Bart Scott is a medical oncologist at Fred Hutchinson Cancer Research Center in Seattle, Washington. He is Professor of Medicine in the Division of Oncology at the University of Washington Medical Center and Director of Myeloid Malignancies at the Seattle Cancer Center Alliance. He is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. Dr. Scott received his medical degree from the University of Alabama. He then completed his internship and residency at the Johns Hopkins University School of Medicine in Baltimore, Maryland. He completed his fellowship in medical oncology at the University of Washington in Seattle. Dr. Scott has participated in a number of studies involving myelodysplastic syndromes and myeloproliferative disorders. He has published numerous articles in journals such as American Journal of Medicine ,  Leukemia & Lymphoma ,  Blood , and  Journal of Clinical Oncology . He is also a reviewer for  New England Journal of Medicine ,  British Journal of Haematology ,  Journal of the National Comprehensive Cancer Network , and  Haematologica , among others. Dr. Scott has been an invited lecturer on the management and treatment of myelodysplastic syndromes and transplantation for bone marrow failure. He is a member of the American Medical Association, the American Society of Hematology, the American Society of Clinical Oncology, and the Southwest Oncology Group, among many others.

Pierre_Fenaux
Pierre Fenaux

Hôpital Saint Louis, Paris, France

Pierre Fenaux, is professor of hematology and head of the hematology department at hospitals St Louis, Robert Debré and Avicenne  (belonging to Assistance Publique- Hôpitaux de Paris Hospital network). He is also part of  Inserm research  unit n° 944, at Hôpital St Louis, Paris, for his laboratory research activity  

He is involved in clinical and laboratory research in the field of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML, mainly AML in the elderly and acute promyelocytic leukemia, APL ). 

He is a founding member and chairman of the French speaking MDS group (Groupe Francophone des Myélodysplasies or GFM) and of the French APL group (GT-LAP).

Immunosuppressive therapy in MDS

Rami Komrokji Intro
Yazan Migdady Intro
Yazan Migdady Presentation
Q&A

Chairperson

Rami Komrokji, MD

Moffitt Cancer Center, Tampa Florida, USA

Faculty

Yazan Migdady

Oregon Health & Science University, Portland, Oregon, USA

Managing isolated neutropenia and thrombocytopenia in Lower risk MDS

Rami Komrokji Intro
Valeria Santini Intro
Valeria Santini Presentation
Q&A
Valeria Santini Slide

Chairperson

Rami Komrokji, MD

Moffitt Cancer Center, Tampa Florida, USA

Faculty

Valeria Santini

University of Florence, Italy

Novel agents for higher risk MDS: be on the look?

Rami Komrokji Intro
David Sallman Intro
David Sallman Presentation
Q&A
David Sallman Slide

Chairperson

Rami Komrokji, MD

Moffitt Cancer Center, Tampa Florida, USA

Faculty

David Sallman

Moffitt Cancer Center, Tampa, Florida, USA

Allogeneic stem cell transplant: how can we cure more patients?

Bart Scott Intro
Bart Scott Presentation
Q&A
Bart Scott Slides

Chairperson

Rami Komrokji, MD

Moffitt Cancer Center, Tampa Florida, USA

Faculty

Bart Scott

University of Washington Medical Center, Seattle, Washington, USA

Luspatercept: where to fit the new kid on the block?

Pierre Fenaux Presentation
Pierre Fenaux Slides
May Q&A Session
Pierre FENAUX summary

Chairperson

Rami Komrokji, MD

Moffitt Cancer Center, Tampa Florida, USA

Faculty

Pierre Fenaux

Hospital Saint Louis, Paris, France